Chronic myeloid leukemia after living donor liver transplantation

Transplantation. 2007 Jun 15;83(11):1521-2. doi: 10.1097/01.tp.0000265587.17307.6a.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibiotics, Antineoplastic / adverse effects
  • Antibiotics, Antineoplastic / therapeutic use
  • Carcinoma, Hepatocellular / pathology
  • Carcinoma, Hepatocellular / surgery*
  • Doxorubicin / adverse effects
  • Doxorubicin / therapeutic use
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / chemically induced
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / etiology*
  • Liver Neoplasms / pathology
  • Liver Neoplasms / surgery*
  • Liver Transplantation / adverse effects*
  • Living Donors*
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Postoperative Care

Substances

  • Antibiotics, Antineoplastic
  • Doxorubicin